You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Financial Ratios    
Bharat Immunologicals & Biologicals Corporation Ltd.
 
BSE Code 524663
ISIN Demat INE994B01014
Book Value -7.54
NSE Code NA
Dividend Yield(%) 0.00
Market Cap(Million) 1309.65
P/E(X) 0.00
EPS(Rs.) -3.85
Face Value(Rs.) 10  
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)-3.85  -2.03  -4.19  -2.36  -1.34  
   CEPS(Rs)-3.81  -1.98  -4.14  -2.31  -1.28  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-5.33  -1.48  0.55  4.74  7.10  
   Tax Rate(%)25.28  9.64  25.18  28.11  21.43  
Margin Ratios          
   Core EBITDA Margin(%)-36.02  -6.34  -24.45  -15.56  -11.14  
   EBIT Margin(%)-34.09  -5.21  -22.76  -14.14  -6.42  
   Pre Tax Margin(%)-49.92  -12.36  -28.37  -21.25  -8.82  
   PAT Margin (%)-37.30  -11.17  -21.23  -15.28  -6.93  
   Cash Profit Margin (%)-36.85  -10.90  -20.95  -14.92  -6.60  
Performance Ratios          
   ROA(%)-9.41  -6.35  -18.41  -8.97  -7.22  
   ROE(%)0.00  0.00  -158.64  -39.93  -17.00  
   ROCE(%)-25.63  -8.08  -73.05  -21.87  -10.70  
   Asset Turnover(x)0.25  0.57  0.87  0.59  1.04  
   Sales/Fixed Asset(x)0.28  0.77  1.87  2.59  14.05  
   Working Capital/Sales(x)-0.77  -2.19  -2.83  -8.69  8.15  
Efficiency Ratios          
   Fixed Capital/Sales(x)3.53  1.30  0.54  0.39  0.07  
   Receivable days61.40  2.66  37.69  247.35  194.00  
   Inventory Days154.12  115.80  139.46  180.65  35.26  
   Payable days8.90  47.94  131.08  286.05  115.09  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-5.83  -14.21  -10.99  -2.52  -6.02  
   Price/Book(x)-4.16  -18.98  83.21  1.23  1.08  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)3.53  2.38  2.50  0.24  0.69  
   EV/Core EBITDA(x)-10.48  -48.10  -11.12  -1.74  -11.29  
   EV/EBIT(x)-10.34  -45.60  -10.98  -1.70  -10.71  
   EV/CE(x)0.97  0.97  2.54  0.14  0.50  
   M Cap / Sales2.15  1.55  2.30  0.38  0.40  
Growth Ratio          
   Net Sales Growth(%)-43.09  -8.14  27.68  -20.10  140.37  
   Core EBITDA Growth(%)-287.70  79.82  -108.19  -80.90  22.05  
   EBIT Growth(%)-272.40  78.97  -105.48  -76.01  22.72  
   PAT Growth(%)-90.08  51.67  -77.38  -76.27  -35.93  
   EPS Growth(%)-90.08  51.67  -77.38  -76.27  -35.93  
Financial Stability Ratios          
   Total Debt/Equity(x)-3.05  -12.18  11.56  0.15  1.05  
   Current Ratio(x)0.38  0.65  0.53  0.92  1.12  
   Quick Ratio(x)0.37  0.29  0.32  0.41  0.95  
   Interest Cover(x)-2.15  -0.73  -4.06  -1.99  -2.68  
   Total Debt/Mcap(x)0.73  0.64  0.14  0.12  0.97